A Clinical Trial Evaluating the Safety and Efficacy of IDP-110 in Patients With Acne Vulgaris

Sponsor
Dow Pharmaceutical Sciences (Industry)
Overall Status
Completed
CT.gov ID
NCT00663286
Collaborator
(none)
1,399
33
4
42.4

Study Details

Study Description

Brief Summary

The purpose of this study is to assess the effectiveness of IDP-110 in treating patients with acne vulgaris.

Condition or Disease Intervention/Treatment Phase
Phase 3

Study Design

Study Type:
Interventional
Actual Enrollment :
1399 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Investigator)
Primary Purpose:
Treatment
Study Start Date :
Oct 1, 2006
Actual Primary Completion Date :
Aug 1, 2007

Arms and Interventions

Arm Intervention/Treatment
Experimental: 1

Drug: IDP-110
Topical application for 12 weeks

Active Comparator: 2

Drug: Clindamycin
Topical application for 12 weeks

Active Comparator: 3

Drug: Benzoyl peroxide
Topical application for 12 weeks

Placebo Comparator: 4

Drug: Vehicle
Topical application for 12 weeks

Outcome Measures

Primary Outcome Measures

  1. Change from baseline in number of lesions [12 weeks]

Secondary Outcome Measures

  1. Change from baseline in global severity [12 weeks]

Eligibility Criteria

Criteria

Ages Eligible for Study:
12 Years to 70 Years
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Presence of inflammatory and non-inflammatory lesions
Exclusion Criteria:
  • Dermatological conditions of the face other than acne that could interfere with clinical evaluations

  • Female subjects who are pregnant, nursing, planning a pregnancy, or become pregnant during the study

Contacts and Locations

Locations

Site City State Country Postal Code
1 Burke Pharmaceutical Research Hot Springs Arkansas United States 71913
2 The Savin Center, PC New Haven Connecticut United States 06511
3 Webster Dermatology, PA Hockessin Delaware United States 19707
4 Skin Care Research, Inc. Boca Raton Florida United States 33486
5 Advanced Dermatology and Cosmetic Surgery Clermont Florida United States 34711
6 North Florida Dermatology Associates, PA Jacksonville Florida United States 32204
7 Advanced Dermatology and Cosmetic Surgery Ormond Beach Florida United States 32174
8 Dermatology Research Pinellas Park Florida United States 33781
9 Florida Dermatology Institute West Palm Beach Florida United States 33401
10 Derm Center of Augusta Augusta Georgia United States 30904
11 MedaPhase Inc. Newnan Georgia United States 30263
12 Gwinnett Clinical Research Center, Inc. Snellville Georgia United States 30078
13 DuPage Medical Group Naperville Illinois United States 60563
14 Hudson Dermatology Evansville Indiana United States 47714
15 South Bend Clinic South Bend Indiana United States 46617
16 Dermatology Specialists Research Louisville Kentucky United States 40202
17 Michigan Center for Research Corp. Clinton Township Michigan United States 48038
18 Minnesota Clinical Study Center Fridley Minnesota United States 55432
19 SUNY Downstate Medical Center Brooklyn New York United States 11203
20 Atlantic Dermatologic Associates, LLP Brooklyn New York United States 11234
21 Office of Fran E. Cook-Bolden, MD New York New York United States 10021
22 Helendale Dermatology and Medical Spa Rochester New York United States 14609
23 Dermatology Associates of Rochester Rochester New York United States 14623
24 DermResearch Center of New York Stony Brook New York United States 11790
25 Central Sooner Research Norman Oklahoma United States 73069
26 Milton S. Hershey Medical Center Hershey Pennsylvania United States 17033
27 DermResearch, Inc. Austin Texas United States 78759
28 J & S Studies, Inc. Bryan Texas United States 77802
29 Thomas J. Stephens & Associates Carrollton Texas United States 75006
30 Dallas Associated Dermatologists Dallas Texas United States 75246
31 Education & Research Foundation Lynchburg Virginia United States 24501
32 Virginia Clinical Research, Inc Norfolk Virginia United States 23507
33 Madison Skin & Research, Inc. Madison Wisconsin United States 53719

Sponsors and Collaborators

  • Dow Pharmaceutical Sciences

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
, ,
ClinicalTrials.gov Identifier:
NCT00663286
Other Study ID Numbers:
  • DPSI-06-22-2006-017
First Posted:
Apr 22, 2008
Last Update Posted:
Apr 22, 2008
Last Verified:
Apr 1, 2008

Study Results

No Results Posted as of Apr 22, 2008